Imatinib Completed Phase N/A Trials for Hypereosinophilic Syndromes / Chronic Myelomonocytic Leukemia / Polycythemia Vera (PV) / Chronic Myeloid Leukemia (CML) / Urticaria Pigmentosa Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00538109An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (GlivecĀ®/GleevecĀ®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
NCT00038675Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate